Camlin Fine Sciences Acquires Majority Stake in Vinpai
November 27, 2025
Camlin Fine Sciences Limited (CFSL) completed the acquisition of a majority stake in Vinpai, acquiring 78.68% of its share capital (and 84.89% of voting rights) for EUR 3.60 per share from certain significant shareholders. CFSL plans to file a simplified cash tender offer (OPAS) with France’s AMF for the remaining Vinpai shares at the same price and, if conditions are met, pursue a mandatory squeeze-out.
- Buyers
- Camlin Fine Sciences Limited (CFSL)
- Targets
- Vinpai
- Sellers
- significant shareholders of Vinpai (the “Sellers”), certain shareholders of Vinpai
- Industry
- Healthcare Services
- Location
- France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
CSL Limited Acquires Vifor Pharma Ltd in All-Cash Tender Offer
December 14, 2021
Pharmaceuticals
CSL Limited entered into a definitive agreement to acquire Vifor Pharma Ltd via an all-cash public tender offer at US$179.25 per share (aggregate equity value about US$11.7 billion). The transaction was funded through a mix of placement, new debt, and existing cash/facilities and was expected to complete around mid-2022, subject to regulatory approvals.
-
PAI Partners Agrees to Acquire Majority Stake in ECF Group
June 14, 2023
Logistics & Distribution
PAI Partners has made a binding offer to acquire a majority stake in ECF Group from French private equity firm Naxicap Partners, with Naxicap remaining a minority investor alongside management. ECF is an omnichannel B2B distributor of equipment, consumables and hygiene products for hospitality and care professionals, headquartered in Grigny, France (~1,750 employees, ~€760m revenue); PAI intends to accelerate growth organically and via acquisitions to consolidate the fragmented market.
-
Bain Capital and Cinven to Acquire Lonza Specialty Ingredients
February 8, 2021
Manufacturing
Bain Capital Private Equity and Cinven have entered into definitive agreements to acquire Lonza Specialty Ingredients (LSI), a division of Lonza AG, for a total enterprise value of CHF 4.2 billion. LSI, headquartered in Basel, Switzerland, is a global provider of specialty chemicals for microbial control with ~2,800 employees, and the consortium intends to invest in R&D, bolster production capabilities and use LSI as a platform for buy-and-build consolidation in the sector; the transaction was expected to close in H2 2021.
-
Cinven Acquires Majority Stake in BioAgilytix; Cobepa Reinvests
December 20, 2021
Healthcare Services
International private equity firm Cinven has agreed to acquire a majority stake in BioAgilytix through a recapitalization, with current investor Cobepa remaining a significant minority investor. GHO Capital has realised its investment and will exit; the transaction will provide funding to support BioAgilytix’s international expansion, capacity and capability investments, and buy-and-build strategy in large-molecule bioanalytical services. BioAgilytix is headquartered in Durham, North Carolina and employs about 870 staff across the United States, Europe and Australia.
-
PAI Partners Acquires Majority Stake in Nutripure
July 25, 2024
Consumer Products
PAI Partners, through its PAI Mid-Market Fund, has agreed to acquire a majority, controlling stake in Nutripure from Ardian. The investment will support Nutripure’s product development, community growth and European expansion while founders and Bpifrance remain shareholders.
-
Valent BioSciences Acquires FBSciences
January 30, 2023
Agriculture
Valent BioSciences LLC, a subsidiary of Sumitomo Chemical Co., Ltd., has acquired FBSciences Holdings, Inc., a Collierville, Tennessee–headquartered developer of naturally derived biostimulants, biopesticides, and crop nutrition solutions. The acquisition strengthens Valent's capabilities and market position in the rapidly growing global biostimulant and biorationals market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.